Trials by therapeutic agent

Pyridostigmine clinical trials

3 post-viral trials on ClinicalTrials.gov · updated October 2026

Last updated 07 October 2026 from ClinicalTrials.gov. Trial statuses are refreshed automatically; check the registry record for the latest status and contact details.

3 trials2 open to enrolment1 completed

All interventional trials in our ClinicalTrials.gov extract that list Pyridostigmine as an intervention, across Unspecified / Overlap (2), Long COVID / PASC (1), ME/CFS (1). 2 are currently open to enrolment and 1 has completed. Read the OSMF evidence profile for Pyridostigmine for literature, mechanism and dosing context.

Intervention names are normalised from the registry's own arm labels, so the same compound can appear under a brand name, a generic name or a combination; check the full agent index for related entries.

⚠️
Not medical advice. This page is an automatically compiled index of entries on ClinicalTrials.gov. Listing here is not an endorsement of any trial, sponsor or treatment, and trial status can change between our refreshes. Always confirm details on ClinicalTrials.gov and discuss participation with your own clinician.

Recruiting (2)

RecruitingPhase 2 NCT00409435
Sponsor: Mayo Clinic (Academic / non-profit / other)
Intervention(s): Pyridostigmine
Condition group: Unspecified / Overlap
Start: Oct 2006  |  Primary completion: Feb 2027  |  Enrollment: 50 (estimated)
Record last updated: Mar 2026

This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to improve tachycardia and stabilize blood pressure.

View on ClinicalTrials.gov ↗
RecruitingPhase 2 NCT06366724
Sponsor: Brigham and Women's Hospital (Academic / non-profit / other)
Condition group: Long COVID / PASC, ME/CFS
Start: Sep 2024  |  Primary completion: Sep 2026  |  Enrollment: 160 (estimated)
Record last updated: Oct 2025

The LIFT will be conducted at Brigham and Women's Hospital (BWH) of Harvard Medical School, focusing on the effect of Pyridostigmine (Mestinon) and Low-Dose Naltrexone (LDN) in subjects aged 18-70 meeting the Canadian consensus criteria (CCC) for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) as well as having specifically Orthostatic Intolerance (OI).

View on ClinicalTrials.gov ↗

Completed (1)

CompletedEarly Phase 1 NCT03261570
Sponsor: New York Medical College (Academic / non-profit / other)
Intervention(s): Pyridostigmine, Digoxin
Condition group: Unspecified / Overlap
Start: Jul 2017  |  Primary completion: Jun 2022  |  Enrollment: 51 (actual)
Record last updated: Sep 2022

Postural tachycardia syndrome (POTS), is the chronic form of orthostatic intolerance associated with excessive upright tachycardia, and occurs predominantly in young females (\>85%). Among its most troubling symptoms are lightheadedness, fatigue, and decreased memory often called "brain fog" by patients.

View on ClinicalTrials.gov ↗

Frequently asked questions

How do I join a clinical trial?

Open the trial's ClinicalTrials.gov record (the "View on ClinicalTrials.gov" button), read the Eligibility Criteria and Contacts and Locations sections, and contact the study team listed there. Trials only enrol at the sites shown in the record, so check whether a site is near you or whether the study is remote/decentralised. Your own clinician can help you judge whether a trial is a sensible option and may need to provide medical records.

What do the trial phases mean?

Early Phase 1 / Phase 1 studies test safety and dosing in a small group. Phase 2 studies look for a signal of benefit in a larger group and keep checking safety. Phase 3 studies are large confirmatory trials designed to show whether a treatment works well enough for approval. Phase 4 studies follow approved treatments after they reach the market. "Phase not applicable" is used by the registry for behavioural, device, rehabilitation and other non-drug interventions.

Does the Open Source Medicine Foundation run these trials?

No. OSMF does not sponsor, run or recruit for any trial on this page. We compile public registry entries from ClinicalTrials.gov so patients and clinicians can find them in one place. For questions about a specific study, contact the sponsor or study team listed on its ClinicalTrials.gov record.

Get new recruiting trials in your inbox.

We summarise newly registered post-viral trials and notable results on the OSMF Substack.

Subscribe on Substack
Cite this page
Open Source Medicine Foundation. Pyridostigmine clinical trials for Long COVID, ME/CFS and post-viral illness (3 trials, updated October 2026). Research Tracker, 07 October 2026. https://research.opensourcemed.info/trials/by-agent/pyridostigmine.html
Underlying dataset (JSON, CC BY 4.0): https://research.opensourcemed.info/data/clinical_trials/clinical_trials_current.json. Source records: ClinicalTrials.gov.

Related: all agents · recruiting Long COVID trials · recruiting ME/CFS trials · open in trial finder.